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Lymphangiogenesis Linked  
to VeGf-C from Tumor-Associated 
Macrophages: Accomplices  
to Metastasis by Cutaneous 
squamous Cell Carcinoma?
Martin S. Kluger1 and Oscar R. Colegio2
During wound healing, dermal macrophages secrete lymphangiogenic 
vascular endothelial growth factor (VeGf)-C, and lymphatic vessels transport 
cytokines and cells to draining lymph nodes. In this issue, Moussai et al. 
show that macrophages in peritumoral nonlesional skin near squamous cell 
carcinoma secrete prolymphangiogenic VeGf-C. Their study suggests how 
tumor-associated macrophages and neolymphatic vessels may coordinate 
metastasis starting early in cutaneous squamous cell carcinoma.
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roles for macrophage and  
lymphatic endothelial cells  
near squamous cell carcinoma
The primary functions of macrophages 
were first characterized in settings of 
classical inflammation in which they 
exert antimicrobial activity, serve as 
antigen-presenting cells required for 
the adaptive immune response, and 
promote healing by tissue remodel-
ing at sites of injury. In contrast, 
tumor-associated macro phages (TAMs) 
are less inflammatory and contribute to 
tissue remodeling by promoting the pro-
liferation and migration of endothelial 
cells (ECs) that lead to growth of new 
lymphatic vessels (lymphangio genesis). 
The presence of TAMs generally 
correlates with a poor prognosis in most 
human cancers. Importantly, whereas 
lymph angiogenesis observed in many 
aggressive cancers correlates with 
meta stasis to regional lymph nodes 
(e.g., in cutaneous melanoma and in 
head/neck and oral squamous cell 
carcinoma (SCC)), the presence and 
character ization of prolymphangiogen-
ic TAMs in cutaneous SCC has not been 
previously described.
In this issue, Moussai et al. describe 
CD68+/CD163+ TAMs in peritumor-
al nonlesional skin (PTNL) of stage I 
cutaneous SCC as a source of vascu-
lar endothelial growth factor (VEGF)-C 
that correlates with an increase in lym-
phatic vessel density (LVD). These data 
showing lymphangio genic VEGF-C 
produced by a defined subpopulation 
of TAMs raise a number of interesting 
questions about how macrophage-driv-
en lymphangiogenesis may promote 
metastasis in SCC. Furthermore, these 
findings invite investigation of mole-
cules expressed by lymphatic endothe-
lial cells (LECs), or at recruitment of 
prolymphangiogenic TAMs, as poten-
tial therapeutic targets for preventing 
life-threatening metastases to regional 
draining lymph nodes.
trophic macrophages are recruited  
by wounds and tumors
Macrophages are bone marrow–derived 
cells that initially circulate as mono-
cytes and subsequently differ entiate 
into tissue-resident macro phages. 
Resident macrophages support tissues 
by phagocytosing apoptotic cells, and 
they become trophic when activated, 
secreting growth, angiogenic, and 
lymphangiogenic factors needed for 
tissue remodeling. Wounding of tis-
sues triggers an acute inflammatory 
response, characterized by the pro-
duction of numerous cyto kines and 
chemokines, which recruit and differ-
entiate additional circulating mono-
cytes into macrophages. Wound-
associated macrophages have been 
proposed to coordinate new tissue 
formation and remodeling. More 
specifically, macrophages have been 
found to regulate vasculogenesis in 
wound healing. Whereas the specific 
commentary
18 Journal of Investigative Dermatology (2011), Volume 131 
roles of wound-associated macro-
phages are incompletely understood, 
TAMs appear to perform similar 
functions in the tumor environment.
A variety of tumors that recruit 
macrophages to tumors have been 
found to produce cytokines in a man-
ner similar to that of wounds (Condeelis 
and Pollard, 2006). VEGF-A is pro-
inflammatory as well as proangiogenic 
and prolymphangiogenic, and its lev-
els are elevated in cutaneous SCC. At 
sufficiently high levels, the leukocyte 
adhesion molecule ICAM-1 is inducible 
by VEGF, which may synergize with 
tumor necrosis factor (also present in 
the SSC microenvironment) to further 
induce ICAM-1 and other leukocyte 
adhesion molecules on the lumenal 
surface of dermal postcapillary venules. 
Efficient recruitment also requires that 
surface chemokines on blood endothe-
lial cells (BECs) engage cognate recep-
tors on circulating monocytes. The 
inflammatory cytokine IL-8, noted 
as upregulated in SCC by Moussai 
et al. (2011), may provide for TAM 
recruitment because firm adhesion of 
monocytes to vascular endothelium is 
IL-8 dependent (Gerszten et al., 1999).
tumor-associated macrophages  
promote tumorigenesis
Whereas the role of these TAMs has yet 
to be clearly characterized, a major-
ity (>80%) of clinical studies correlate 
an increased number of TAMs with a 
worse prognosis (Pollard, 2004). Several 
in vivo studies have supported these 
clinical observations: mice deficient in 
colony-stimulating factor-1 (CSF-1) and 
thus deficient in macrophages, when 
crossed with mice expressing a breast 
epithelium-specific oncogene, exhibit 
delayed tumor progression and nearly no 
metastases (Lin et al., 2001). Local trans-
genic expression of CSF-1 in the breasts 
of these CSF-1-deficient mice results in 
a rate of metastasis equivalent to that of 
wild-type mice, suggesting that mac-
rophages are necessary for metastasis.
Macrophages can be found in most 
tissues of the body and as such serve a 
broad variety of functions. Classification 
of macrophage subtypes has been 
attempted according to functional and 
transcriptional differences. M1, or “class-
ically activated,” macrophages require 
priming by the T helper type 1 (Th1)-type 
cytokines IFN-γ, IL-12, and IL-23 or by 
microbial products such as lipopolysac-
charide. M1 macrophages are best char-
acterized for their cell-mediated antimi-
crobial functions. M2, or “alternatively 
activated,” macrophages are primed 
by the Th2-type cytokines IL-4 and 
IL-13 and have functions that include 
humoral-mediated anti microbial func-
tions as well as tissue repair and fibrosis. 
The characterization of M1 and M2 
macrophages defines extremes of a 
spectrum of phenotypes. Whereas 
the TAM transcriptional program is 
unique, it reveals an M2-like phenotype 
with an increase in expression of the 
immunosuppressive cytokine IL-10, 
lymphangiogenic and angiogenic growth 
factors, metallo proteases, and IFN-
inducible cytokines (Pollard, 2009). In 
cervical SCC, where LVD is increased 
in the peritumoral stroma, TAMs that 
are recruited to the tumor as mono-
cytes are subsequently “educated” by 
the tumor environment, and the same 
process may occur with cutaneous SCC 
(referenced in Moussai et al., 2011). But 
whereas the factors required for prim-
ing monocytes to become M1 and M2 
macrophages have been well charac-
terized, the factors that prime recruited 
monocytes to become TAMs have yet to 
be identified.
tumor-associated macrophages  
express VeGF-c
It has been well established that 
macrophages have a significant bio-
synthetic capacity for secreted proteins, 
including angiogenic factors. Elevated 
levels of VEGF-C expression and LVD 
have been positively correlated with 
metastasis in breast, colon, lung, and 
prostate cancers. Certainly in human 
melanoma increased LVD has emerged 
as a rational basis for flagging high risk 
for nodal metastasis and decreased sur-
vival (Dadras et al., 2005). Germane to 
the current study, VEGF-C expression 
has been associated with tumor pro-
gression in SCCs of the head and neck 
and cervix. Moussai et al. demonstrate 
for the first time that cutaneous SCC, 
like cervical SCC, has increased LVD 
as compared with normal skin and that 
TAMs are the stromal cell type respon-
sible for the production of VEGF-C. The 
factors within the tumor environment 
that induce the production of VEGF-C 
are the subject of intense investiga-
tion. Whether these findings correlate 
with a prognosis indicating increased 
propensity for nodal metastasis in cuta-
neous SCC has yet to be determined.
Structure and function of normal and 
tumor-associated lymphatic vessels
The physiologic role for tumor-
 associated lymphangiogenesis may 
recapitulate programs of wound healing 
and/or development. First described 
as “milky veins” in the seventeenth 
century, lymphatic vessels provide 
unidirectional transport of fluid, macro-
molecules, and antigen-presenting cells 
to draining lymph nodes. The lymphatic 
system sprouts from the existing blood 
microvasculature during embryonic 
development in response to VEGF-C to 
form primitive lymph sacs and, in an 
orderly progression, expresses genes 
specifying lymphatic identity (early 
markers are Prox1, VEGFR-3, and 
podoplanin). Later, maturation of the 
lymphatic vasculature involves angio-
poietin 2 and new gene expression 
(of ephrinB2, neuropilin2, and tran-
scription factors such as Foxc2). It is 
still unclear how lymphangiogenesis 
near SCC tumors may recapitulate the 
carefully orchestrated developmental 
program of lymphangiogenesis.
Clinical Implications
•  Responses of dermal macrophage and lymphatic endothelial cells may 
serve as prognostic indicators for cutaneous squamous cell carcinomas.
•  Investigation of molecules expressed by lymphatic endothelial cells 
or prolymphangiogenic tumor-associated macrophages may reveal 
potential therapeutic targets for treatment of early skin cancers.
•  Investigation of such molecules may also lead to early detection of 
aggressive disease or the prevention of life-threatening metastases.
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The mechanism(s) by which tumor 
cells gain entry to lymphatics is not 
well described. Compared with blood 
vessels, lymphatics are thin walled and 
lack a continuous basement membrane. 
Recent evidence shows VE-cadherin 
and tight junction proteins (occludin, 
claudin-5, JAM-A, ESAM) expressed at 
the initial openings of lymphatics (Baluk 
et al., 2007). Described as buttons 
designed to open and close for leuko-
cyte entry, to the extent that lymphatic 
entry by cells is a selective process, such 
structures may be relevant for regulat-
ing tumor metastasis. Intraendothelial 
channels found in normal and tumor-
associated lymph atic vessels support an 
alternative, transendothelial modality for 
tumor cell intravasation that is junction 
independent. VEGF-C stimulates dilation 
of preexisting lymphatics, correspond-
ing to an increase in LN-directed flow, 
so it is also possible that lymphangio-
genesis may promote metastasis simply 
by increasing the rate of transport and/or 
amount of lymphatic surface available 
for contact with malignant cells.
targeting the VeGF-c pathway  
to impede metastasis
VEGF-C signals through the tyrosine 
kinase receptor VEGFR-3 (Flt-4) that in 
normal healthy adult skin is restricted 
to the lymphatic vasculature. Early in 
development, continuous VEGFR-3 sig-
naling ensures survival of lymphatic EC, 
but this dependency wanes in postna-
tal development. Therefore, VEGFR-3-
inhibitory therapies may spare normal 
lymphatic cells while selectively inter-
fering with the formation of new peritu-
moral lymphatic vessels. Cancer inves-
tigators have pursued an assortment of 
strategies by targeting VEGFR-3 with 
neutralizing antibodies, decoy VEGFR-3 
fusion proteins, and siRNA approaches. 
Still to be gauged, however, is the extent 
to which dermal lymphatic vessels 
formed during development contribute 
or whether tumoral lymphangiogenesis 
is absolutely required for nodal metas-
tasis to occur in human cutaneous SCC.
Only in the past decade have anti-
body tools for differentiating LECs 
become available, coinciding with com-
prehensive studies comparing differen-
tial gene expression by purified human 
blood and lymphatic microvascular ECs. 
Moussai et al. (2011) used a database 
of genes enriched in cultured LECs over 
cultured BECs (see Supplemental Table 
III in Petrova et al., 2002) for gene set 
enrichment analysis on cDNA transcripts 
derived from the PTNL of cutaneous 
SCC. Interestingly, more so than normal 
skin or intratumoral SSC, nonlesional 
skin adjacent to tumors was enriched for 
gene transcripts found highly expressed 
by differentiated LECs. Moussai et al. 
(2011) also used quantitative real-time 
reverse transcription–PCR to show that 
neuropilin-2 (NRP-2), a VEGFR-3 core-
ceptor for VEGF-C, is elevated in PTNL 
regions surrounding SSC tumors. NRP-2 
was originally found to be important for 
neuronal axon guidance but has more 
recently been implicated in regulating 
tumor lymphangiogenesis and nodal 
metastases. Specifically, Caunt et al. 
(2008) designed a monoclonal antibody 
targeting the VEGF-C-binding domain 
of NRP-2 that reduced LVD near tumors 
(formed by subcutaneously implanting a 
murine mammary carcinoma line) with-
out harming normal lymphatics and that 
significantly delayed metastasis of carci-
noma cells to the primary lymph node. 
Collectively, these data support a role for 
NRP-2 in controlling lymphangiogenesis 
and tumor cell migration that deserves 
further attention with respect to invasive 
cutaneous SCC.
conclusion
These observations emphasize that 
responses of dermal macrophage and 
LECs may serve as prognostic indicators 
during early stage I disease and may 
provide clues toward reaching a deeper 
understanding of how cutaneous SCC 
metastasizes. Further investigation of 
molecules expressed by LECs or pro-
lymphangiogenic TAMs as potential 
therapeutic targets for early detection 
of aggressive disease or for preventing 
life-threatening metastases to regional 
draining lymph nodes is needed.
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